Award
NIH Reporter #11370682
Selective Inhibition of GRP 94 to Treat Ocular Hypertension and Glaucoma
Recipient
University of Notre Dame
Award Amount
$591,767.00
Ceiling
$591,767.00
Awarded
July 27, 2026
Identifier
11370682
NIH grant awarded to University of Notre Dame for research on selective inhibition of GRP94 to treat ocular hypertension and glaucoma, total funding $591,767.
Description
This is a NIH grant project focused on developing selective inhibitors of GRP94 for glaucoma treatment, with a total award amount of $591,767, funded by the National Eye Institute. The project involves multiple investigators and aims to optimize lead compounds and elucidate their mechanisms of action.